Concepedia

Ellen R. Rowley

ER

10

Publications

1.2K

Citations

10

H-Index

1994

Active since

Affiliations

Eli Lilly (United States)(Current)

Ellen R. Rowley is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1994–2005

10

Publications

10

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

Larry J. Black, Masahiko Sato, Ellen R. Rowley et al. · Journal of Clinical Investigation · 1994 · 612 citations · Full text

, , +20

Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene

Timothy A. Grese, Stephen Cho, Don R. Finley et al. · Journal of Medicinal Chemistry · 1997 · 175 citations · Full text

, , +23

LY353381.HCl: A Novel Raloxifene Analog with Improved SERM Potency and Efficacy In Vivo

Masahiko Sato, Charles H. Turner, Tongyu Wang et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 133 citations

Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators

Timothy A. Grese, Lewis D. Pennington, James P. Sluka et al. · Journal of Medicinal Chemistry · 1998 · 126 citations

Abnormal Bone Architecture and Biomechanical Properties with Near-Lifetime Treatment of Rats with PTH

Masahiko Sato, John L. Vahle, Allen Schmidt et al. · Endocrinology · 2002 · 68 citations · Full text

, , +18

Rows per page

1–5 of 10